2025年8月27日，华兰股份(301093.SZ)发布2025年半年度报告。截至2025年8月26日，共有10个机构投 资者披露持有华兰股份A股股份，合计持股量达5660.92万股，占华兰股份总股本的44.82%。其中，前 十大机构投资者包括江阴华兰机电科技有限公司、瑞众人寿保险有限责任公司-自有资金、上海磬晟私 募基金管理有限公司-磬晟联盈五号私募证券投资基金、江阴华恒投资有限公司、和盛财富(北京)基金管 理有限公司-和盛财富甄选七号私募证券投资基金、中国银河证券股份有限公司、长江智能制造混合型 发起式A、大成创业板两年定开混合A、银河康乐股票A、长江旭日混合A，前十大机构投资者合计持股 比例达44.82%。相较于上一季度，前十大机构持股比例合计下跌了4.34个百分点。 公募基金方面本期较上一季度持股减少的公募基金共计3个，包括长江智能制造混合型发起式A、长江 旭日混合A、银河康乐股票A，持股减少占比达0.26%。本期较上一季度新披露的公募基金共计1个，即 大成创业板两年定开混合A。 以上内容与数据，与有连云立场无关，不构成投资建议。据此操作，风险自担。 对于社保基金，本期较上一季未再披露的社保基金共计1 ...

证券代码：301093 证券简称：华兰股份 公告编号：2025-083 一、重要提示 本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投 资者应当到证监会指定媒体仔细阅读半年度报告全文。 所有董事均已出席了审议本报告的董事会会议。 非标准审计意见提示 □适用 √不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 □适用 √不适用 公司计划不派发现金红利，不送红股，不以公积金转增股本。 ■ 董事会决议通过的本报告期优先股利润分配预案 □适用 √不适用 二、公司基本情况 3、公司股东数量及持股情况 单位：股 ■ 1、公司简介 公司是否需追溯调整或重述以前年度会计数据 □是 √否 持股5%以上股东、前10名股东及前10名无限售流通股股东参与转融通业务出借股份情况 □适用 √不适用 前10名股东及前10名无限售流通股股东因转融通出借/归还原因导致较上期发生变化 □适用 √不适用 公司是否具有表决权差异安排 □是 √否 4、控股股东或实际控制人变更情况 ■ 2、主要会计数据和财务指标 控股股东报告期内变更 □适用 √不适用 公司报告期控股股东未发生变更。 实际控制人报告期 ...

Group 1 - The board of directors of Jiangsu Hualan Pharmaceutical New Materials Co., Ltd. held its fourth meeting of the sixth session on August 15, 2025, with all nine directors present, ensuring compliance with relevant laws and regulations [1] - The board approved the annual report and its summary, with detailed content available on the company's disclosure platform [1][2] - The board also approved a special report on the use of raised funds, which was reviewed by the audit committee [2][3] Group 2 - The board authorized the core management team to handle changes related to the raised funds account, including the cancellation and opening of accounts [3] - A temporary shareholders' meeting is scheduled for September 15, 2025, to discuss various proposals, including changes to the company's registered capital and amendments to the articles of association [2][3] - The company aims to improve the efficiency of fund usage by transferring the balance of raised funds to a different bank account [2][3]

Meeting Overview - The company, Jiangsu Hualan Pharmaceutical Materials Co., Ltd., will hold its fourth extraordinary general meeting of shareholders on September 15, 2025, at 14:30 [1][2] - The meeting will be conducted in a hybrid format, combining on-site and online voting [2][5] - The legal compliance of the meeting has been confirmed according to relevant laws and regulations [1][2] Voting Details - Shareholders can vote either in person or through an authorized representative [2][5] - The record date for shareholders eligible to vote is September 9, 2025 [2][4] - The meeting will include a special resolution that requires approval from more than two-thirds of the voting rights held by attending shareholders [3][4] Registration Information - Registration for the meeting will take place on September 12, 2025, from 8:30 to 12:00 and 13:00 to 17:00 [4] - Specific documents are required for registration, including shareholder account cards and identification [4][5] Online Voting Process - Shareholders can participate in online voting through the Shenzhen Stock Exchange's trading system and internet voting system [5][7] - The online voting period will be from 9:15 to 15:00 on September 15, 2025 [2][5] Additional Information - The meeting is expected to last half a day, with attendees responsible for their own travel and accommodation expenses [5][6] - Contact information for inquiries regarding the meeting is provided [5][6]

Core Viewpoint - Hualan Co., Ltd. reported a revenue of 309 million yuan for the first half of 2025, reflecting a year-on-year growth of 8.82% [1] - The net profit attributable to shareholders reached 43.73 million yuan, an increase of 18.27% compared to the previous year [1] - The net profit excluding non-recurring gains and losses was 34.82 million yuan, showing a significant growth of 42.18% year-on-year [1] - The basic earnings per share stood at 0.27 yuan [1] Financial Performance - Revenue for the first half of 2025: 309 million yuan, up 8.82% year-on-year [1] - Net profit attributable to shareholders: 43.73 million yuan, up 18.27% year-on-year [1] - Net profit excluding non-recurring items: 34.82 million yuan, up 42.18% year-on-year [1] - Basic earnings per share: 0.27 yuan [1]

证券日报网讯 8月26日晚间，华兰股份发布公告称，公司第六届董事会第四次会议审议通过了《关于及 其摘要的议案》等多项议案。 （文章来源：证券日报） ...

证券日报网讯 8月26日晚间，华兰股份发布公告称，2025年半年度公司实现营业收入308，761，762.58 元，同比增长8.82%；归属于上市公司股东的净利润为43，732，122.30元，同比增长18.27%。 （编辑 何成浩） ...

证券日报网讯 8月26日晚间，华兰股份发布公告称，董事会同意公司对组织架构进行优化调整。 （文章来源：证券日报） ...

（编辑 楚丽君） 证券日报网讯 8月26日晚间，华兰股份发布公告称，公司于2025年8月25日召开第六届董事会第四次会 议，审议通过了《关于变更部分募集资金专户的议案》。董事会同意公司将存放于募集资金专户（中国 民生银行股份有限公司北京分行，银行账号：632342624）的募集资金余额（实际金额以资金转出当日 募集资金专户余额为准）转存至招商银行股份有限公司上海四平支行。同时董事会授权公司核心管理层 办理本次变更部分募集资金专户的相关事宜，包括但不限于募集资金专户的注销、开立、签署募集资金 三方监管协议等。 ...

智通财经APP讯，华兰股份(301093.SZ)发布2025年半年度报告，该公司营业收入为3.09亿元，同比增长 8.82%。归属于上市公司股东的净利润为4373.21万元，同比增长18.27%。归属于上市公司股东的扣除非 经常性损益的净利润为3481.96万元，同比增长42.18%。基本每股收益为0.27元。 ...